• Je něco špatně v tomto záznamu ?

Leishmania infections: Molecular targets and diagnosis

M. Akhoundi, T. Downing, J. Votýpka, K. Kuhls, J. Lukeš, A. Cannet, C. Ravel, P. Marty, P. Delaunay, M. Kasbari, B. Granouillac, L. Gradoni, D. Sereno,

. 2017 ; 57 (-) : 1-29. [pub] 20170131

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc18025170

Progress in the diagnosis of leishmaniases depends on the development of effective methods and the discovery of suitable biomarkers. We propose firstly an update classification of Leishmania species and their synonymies. We demonstrate a global map highlighting the geography of known endemic Leishmania species pathogenic to humans. We summarize a complete list of techniques currently in use and discuss their advantages and limitations. The available data highlights the benefits of molecular markers in terms of their sensitivity and specificity to quantify variation from the subgeneric level to species complexes, (sub) species within complexes, and individual populations and infection foci. Each DNA-based detection method is supplied with a comprehensive description of markers and primers and proposal for a classification based on the role of each target and primer in the detection, identification and quantification of leishmaniasis infection. We outline a genome-wide map of genes informative for diagnosis that have been used for Leishmania genotyping. Furthermore, we propose a classification method based on the suitability of well-studied molecular markers for typing the 21 known Leishmania species pathogenic to humans. This can be applied to newly discovered species and to hybrid strains originating from inter-species crosses. Developing more effective and sensitive diagnostic methods and biomarkers is vital for enhancing Leishmania infection control programs.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18025170
003      
CZ-PrNML
005      
20180718114656.0
007      
ta
008      
180709s2017 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.mam.2016.11.012 $2 doi
035    __
$a (PubMed)28159546
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Akhoundi, Mohammad $u Service de Parasitologie-Mycologie, Hôpital de l'Archet, Centre Hospitalier Universitaire de Nice, Nice, France; MIVEGEC, UMR CNRS5290-IRD224-Université de Montpellier Centre IRD, Montpellier, France. Electronic address: m.akhoundi@yahoo.com.
245    10
$a Leishmania infections: Molecular targets and diagnosis / $c M. Akhoundi, T. Downing, J. Votýpka, K. Kuhls, J. Lukeš, A. Cannet, C. Ravel, P. Marty, P. Delaunay, M. Kasbari, B. Granouillac, L. Gradoni, D. Sereno,
520    9_
$a Progress in the diagnosis of leishmaniases depends on the development of effective methods and the discovery of suitable biomarkers. We propose firstly an update classification of Leishmania species and their synonymies. We demonstrate a global map highlighting the geography of known endemic Leishmania species pathogenic to humans. We summarize a complete list of techniques currently in use and discuss their advantages and limitations. The available data highlights the benefits of molecular markers in terms of their sensitivity and specificity to quantify variation from the subgeneric level to species complexes, (sub) species within complexes, and individual populations and infection foci. Each DNA-based detection method is supplied with a comprehensive description of markers and primers and proposal for a classification based on the role of each target and primer in the detection, identification and quantification of leishmaniasis infection. We outline a genome-wide map of genes informative for diagnosis that have been used for Leishmania genotyping. Furthermore, we propose a classification method based on the suitability of well-studied molecular markers for typing the 21 known Leishmania species pathogenic to humans. This can be applied to newly discovered species and to hybrid strains originating from inter-species crosses. Developing more effective and sensitive diagnostic methods and biomarkers is vital for enhancing Leishmania infection control programs.
650    _2
$a zvířata $7 D000818
650    _2
$a antiprotozoální látky $x farmakologie $7 D000981
650    _2
$a protozoální DNA $x genetika $7 D016054
650    _2
$a genotyp $7 D005838
650    _2
$a lidé $7 D006801
650    _2
$a hmyz - vektory $x parazitologie $7 D007303
650    _2
$a Leishmania $x klasifikace $x účinky léků $x genetika $x izolace a purifikace $7 D007891
650    _2
$a leishmanióza $x klasifikace $x farmakoterapie $x epidemiologie $x přenos $7 D007896
650    _2
$a molekulární typizace $x přístrojové vybavení $x metody $7 D058889
650    12
$a fylogeneze $7 D010802
650    _2
$a fylogeografie $7 D058974
650    _2
$a protozoální proteiny $x genetika $7 D015800
650    _2
$a Psychodidae $x parazitologie $7 D011576
650    _2
$a senzitivita a specificita $7 D012680
650    _2
$a druhová specificita $7 D013045
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Downing, Tim $u School of Biotechnology, Dublin City University, Dublin, Ireland.
700    1_
$a Votýpka, Jan $u Biology Centre, Institute of Parasitology, Czech Academy of Sciences, České Budějovice, Czech Republic; Department of Parasitology, Faculty of Science, Charles University in Prague, Prague, Czech Republic.
700    1_
$a Kuhls, Katrin $u Division of Molecular Biotechnology and Functional Genomics, Technical University of Applied Sciences Wildau, Wildau, Germany.
700    1_
$a Lukeš, Julius $u Biology Centre, Institute of Parasitology, Czech Academy of Sciences, České Budějovice, Czech Republic; Faculty of Sciences, University of South Bohemia, České Budějovice, Czech Republic; Canadian Institute for Advanced Research, Toronto, Canada.
700    1_
$a Cannet, Arnaud $u Inserm U1065, Centre Méditerranéen de Médecine Moléculaire, Université de Nice-Sophia Antipolis, Nice, France.
700    1_
$a Ravel, Christophe $u French National Reference Centre on Leishmaniasis, Montpellier University, Montpellier, France.
700    1_
$a Marty, Pierre $u Service de Parasitologie-Mycologie, Hôpital de l'Archet, Centre Hospitalier Universitaire de Nice, Nice, France; Inserm U1065, Centre Méditerranéen de Médecine Moléculaire, Université de Nice-Sophia Antipolis, Nice, France.
700    1_
$a Delaunay, Pascal $u Service de Parasitologie-Mycologie, Hôpital de l'Archet, Centre Hospitalier Universitaire de Nice, Nice, France; Inserm U1065, Centre Méditerranéen de Médecine Moléculaire, Université de Nice-Sophia Antipolis, Nice, France; MIVEGEC, UMR CNRS5290-IRD224-Université de Montpellier Centre IRD, Montpellier, France.
700    1_
$a Kasbari, Mohamed $u Agence Nationale de Sécurité Sanitaire de l'Alimentation, de l'Environnement et du Travail, ANSES, Laboratoire de Santé Animale, Maisons-Alfort, Cedex, France.
700    1_
$a Granouillac, Bruno $u IRD/UMI 233, INSERM U1175, Montpellier University, Montpellier, France; MIVEGEC, UMR CNRS5290-IRD224-Université de Montpellier Centre IRD, Montpellier, France.
700    1_
$a Gradoni, Luigi $u Unit of Vector-borne Diseases and International Health, Istituto Superiore di Sanità, Rome, Italy.
700    1_
$a Sereno, Denis $u MIVEGEC, UMR CNRS5290-IRD224-Université de Montpellier Centre IRD, Montpellier, France; Intertryp UMR IRD177, Centre IRD de Montpellier, Montpellier, France.
773    0_
$w MED00003389 $t Molecular aspects of medicine $x 1872-9452 $g Roč. 57, č. - (2017), s. 1-29
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28159546 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180709 $b ABA008
991    __
$a 20180718114956 $b ABA008
999    __
$a ok $b bmc $g 1317301 $s 1022091
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 57 $c - $d 1-29 $e 20170131 $i 1872-9452 $m Molecular aspects of medicine $n Mol Aspects Med $x MED00003389
LZP    __
$a Pubmed-20180709

Najít záznam

Citační ukazatele

Možnosti archivace